(-)-epigallocatechin 3-gallate multiple interactions ISO RGD:30302009 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of DAB2 mRNA CTD PMID:22079256 1,2-dichloroethane decreases expression ISO RGD:731452 6480464 ethylene dichloride results in decreased expression of DAB2 mRNA CTD PMID:28960355 1,2-dimethylhydrazine decreases expression ISO RGD:731452 6480464 1, 2-Dimethylhydrazine results in decreased expression of DAB2 mRNA CTD PMID:22206623 1,2-dimethylhydrazine multiple interactions EXP 6480464 [APC protein affects the susceptibility to 1, 2-Dimethylhydrazine] which results in decreased expression of DAB2 mRNA CTD PMID:27840820 17alpha-ethynylestradiol affects expression EXP 6480464 Ethinyl Estradiol affects the expression of DAB2 mRNA CTD PMID:17351261 17beta-estradiol increases expression ISO RGD:731452 6480464 Estradiol results in increased expression of DAB2 mRNA CTD PMID:19484750 17beta-estradiol multiple interactions ISO RGD:30302009 6480464 [Estradiol co-treated with Tetrachlorodibenzodioxin] results in increased expression of DAB2 mRNA, [Estradiol co-treated with TGFB1 protein] results in increased expression of DAB2 mRNA CTD PMID:19619570 , PMID:30165855 17beta-estradiol decreases expression ISO RGD:30302009 6480464 Estradiol results in decreased expression of DAB2 mRNA CTD PMID:28711546 , PMID:31614463 17beta-estradiol affects expression ISO RGD:30302009 6480464 Estradiol affects the expression of DAB2 mRNA CTD PMID:22574217 17beta-estradiol increases expression ISO RGD:30302009 6480464 Estradiol results in increased expression of DAB2 mRNA CTD PMID:19619570 2,2',4,4'-Tetrabromodiphenyl ether decreases expression ISO RGD:30302009 6480464 2 more ... CTD PMID:31675489 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:731452 6480464 Tetrachlorodibenzodioxin results in increased expression of DAB2 mRNA CTD PMID:18691609 , PMID:19933214 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:30302009 6480464 Tetrachlorodibenzodioxin results in increased expression of DAB2 mRNA CTD PMID:19619570 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of DAB2 mRNA CTD PMID:33387578 , PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:30302009 6480464 Tetrachlorodibenzodioxin results in decreased expression of DAB2 mRNA CTD PMID:20106945 , PMID:21632981 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:30302009 6480464 [Estradiol co-treated with Tetrachlorodibenzodioxin] results in increased expression of DAB2 mRNA CTD PMID:19619570 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:731452 6480464 Tetrachlorodibenzodioxin results in decreased expression of DAB2 mRNA CTD PMID:33956508 3,3',5,5'-tetrabromobisphenol A decreases expression ISO RGD:30302009 6480464 tetrabromobisphenol A results in decreased expression of DAB2 protein CTD PMID:31675489 3,4-methylenedioxymethamphetamine decreases expression EXP 6480464 N-Methyl-3, 4-methylenedioxyamphetamine results in decreased expression of DAB2 mRNA CTD PMID:30071829 3-methylcholanthrene increases expression ISO RGD:731452 6480464 Methylcholanthrene results in increased expression of DAB2 mRNA CTD PMID:20713471 4,4'-sulfonyldiphenol increases expression ISO RGD:731452 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of DAB2 mRNA CTD PMID:30951980 4,4'-sulfonyldiphenol multiple interactions ISO RGD:731452 6480464 [bis(4-hydroxyphenyl)sulfone co-treated with Tretinoin] results in decreased expression of DAB2 mRNA CTD PMID:30951980 4-hydroxyphenyl retinamide increases expression ISO RGD:731452 6480464 Fenretinide results in increased expression of DAB2 mRNA CTD PMID:28973697 6-propyl-2-thiouracil decreases expression EXP 6480464 Propylthiouracil results in decreased expression of DAB2 mRNA CTD PMID:24780913 , PMID:25825206 acetamide increases expression EXP 6480464 acetamide results in increased expression of DAB2 mRNA CTD PMID:31881176 acrylamide decreases expression EXP 6480464 Acrylamide results in decreased expression of DAB2 mRNA CTD PMID:28959563 afimoxifene increases expression ISO RGD:30302009 6480464 afimoxifene results in increased expression of DAB2 mRNA CTD PMID:16849584 aldosterone multiple interactions EXP 6480464 AGT protein affects the reaction [DAB2 protein results in increased secretion of Aldosterone] CTD PMID:17303656 all-trans-retinoic acid multiple interactions ISO RGD:731452 6480464 [bis(4-hydroxyphenyl)sulfone co-treated with Tretinoin] results in decreased expression of DAB2 mRNA more ... CTD PMID:30951980 all-trans-retinoic acid increases expression ISO RGD:30302009 6480464 Tretinoin results in increased expression of DAB2 mRNA CTD PMID:17138961 more ... all-trans-retinoic acid increases expression ISO RGD:731452 6480464 Tretinoin results in increased expression of DAB2 mRNA CTD PMID:16788091 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of DAB2 mRNA CTD PMID:16483693 amphetamine increases expression EXP 6480464 Amphetamine results in increased expression of DAB2 mRNA CTD PMID:30779732 antirheumatic drug decreases expression ISO RGD:30302009 6480464 Antirheumatic Agents results in decreased expression of DAB2 mRNA CTD PMID:24449571 arsane multiple interactions ISO RGD:30302009 6480464 [sodium arsenate results in increased abundance of Arsenic] which results in increased expression of DAB2 mRNA CTD PMID:32525701 arsenic atom multiple interactions ISO RGD:30302009 6480464 [sodium arsenate results in increased abundance of Arsenic] which results in increased expression of DAB2 mRNA CTD PMID:32525701 arsenous acid affects expression ISO RGD:30302009 6480464 Arsenic Trioxide affects the expression of DAB2 mRNA CTD PMID:28786057 arsenous acid decreases expression ISO RGD:30302009 6480464 Arsenic Trioxide results in decreased expression of DAB2 mRNA CTD PMID:22521957 benzo[a]pyrene increases expression ISO RGD:731452 6480464 Benzo(a)pyrene results in increased expression of DAB2 mRNA CTD PMID:20713471 more ... benzo[a]pyrene decreases expression ISO RGD:30302009 6480464 Benzo(a)pyrene results in decreased expression of DAB2 mRNA CTD PMID:20106945 more ... benzo[a]pyrene affects methylation ISO RGD:30302009 6480464 Benzo(a)pyrene affects the methylation of DAB2 5' UTR CTD PMID:27901495 benzo[a]pyrene diol epoxide I decreases expression ISO RGD:30302009 6480464 7 more ... CTD PMID:19150397 , PMID:20018196 benzo[b]fluoranthene increases expression ISO RGD:731452 6480464 benzo(b)fluoranthene results in increased expression of DAB2 mRNA CTD PMID:26377693 bexarotene decreases expression EXP 6480464 Bexarotene results in decreased expression of DAB2 mRNA CTD PMID:16648578 bisphenol A increases expression ISO RGD:731452 6480464 bisphenol A results in increased expression of DAB2 mRNA CTD PMID:30951980 , PMID:34585602 bisphenol A multiple interactions ISO RGD:30302009 6480464 [bisphenol A co-treated with Fulvestrant] results in increased methylation of DAB2 gene CTD PMID:31601247 bisphenol A increases methylation ISO RGD:30302009 6480464 bisphenol A results in increased methylation of DAB2 gene CTD PMID:31601247 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of DAB2 mRNA CTD PMID:30816183 , PMID:34947998 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of DAB2 mRNA CTD PMID:25181051 , PMID:33296240 bisphenol A increases methylation EXP 6480464 bisphenol A results in increased methylation of DAB2 gene CTD PMID:28505145 bisphenol A increases expression ISO RGD:30302009 6480464 bisphenol A results in increased expression of DAB2 mRNA CTD PMID:29275510 bisphenol A multiple interactions ISO RGD:731452 6480464 [bisphenol A co-treated with Tretinoin] results in decreased expression of DAB2 mRNA CTD PMID:30951980 Bisphenol B increases expression ISO RGD:30302009 6480464 bisphenol B results in increased expression of DAB2 protein CTD PMID:34186270 bisphenol F multiple interactions ISO RGD:731452 6480464 [bisphenol F co-treated with Tretinoin] results in decreased expression of DAB2 mRNA CTD PMID:30951980 bisphenol F increases expression ISO RGD:731452 6480464 bisphenol F results in increased expression of DAB2 mRNA CTD PMID:30951980 buspirone decreases expression EXP 6480464 Buspirone results in decreased expression of DAB2 mRNA CTD PMID:24136188 cadmium atom increases expression ISO RGD:30302009 6480464 Cadmium results in increased expression of DAB2 mRNA CTD PMID:24376830 cadmium dichloride multiple interactions ISO RGD:30302009 6480464 [sodium arsenite co-treated with Cadmium Chloride co-treated with chromic oxide co-treated with chromous chloride co-treated with lead acetate] results in decreased expression of DAB2 mRNA CTD PMID:12634122 caffeine decreases phosphorylation ISO RGD:30302009 6480464 Caffeine results in decreased phosphorylation of DAB2 protein CTD PMID:35688186 carbon nanotube decreases expression ISO RGD:731452 6480464 Nanotubes more ... CTD PMID:25620056 chloroprene decreases expression ISO RGD:731452 6480464 Chloroprene results in decreased expression of DAB2 mRNA CTD PMID:23125180 ciguatoxin CTX1B affects expression ISO RGD:731452 6480464 Ciguatoxins affects the expression of DAB2 mRNA CTD PMID:18353800 cisplatin increases expression ISO RGD:731452 6480464 Cisplatin results in increased expression of DAB2 mRNA CTD PMID:21151649 cisplatin decreases response to substance ISO RGD:30302009 6480464 DAB2 protein results in decreased susceptibility to Cisplatin CTD PMID:16734730 clozapine increases expression ISO RGD:30302009 6480464 Clozapine results in increased expression of DAB2 protein CTD PMID:36482696 cobalt dichloride decreases expression ISO RGD:30302009 6480464 cobaltous chloride results in decreased expression of DAB2 mRNA CTD PMID:19320972 crocidolite asbestos increases expression ISO RGD:30302009 6480464 Asbestos, Crocidolite results in increased expression of DAB2 mRNA CTD PMID:25351596 Cuprizon increases expression EXP 6480464 Cuprizone results in increased expression of DAB2 mRNA CTD PMID:26577399 cyclosporin A decreases expression ISO RGD:30302009 6480464 Cyclosporine results in decreased expression of DAB2 mRNA CTD PMID:27989131 cytarabine decreases expression ISO RGD:30302009 6480464 Cytarabine results in decreased expression of DAB2 mRNA CTD PMID:21198554 decabromodiphenyl ether decreases expression ISO RGD:30302009 6480464 decabromobiphenyl ether results in decreased expression of DAB2 protein CTD PMID:31675489 diarsenic trioxide affects expression ISO RGD:30302009 6480464 Arsenic Trioxide affects the expression of DAB2 mRNA CTD PMID:28786057 diarsenic trioxide decreases expression ISO RGD:30302009 6480464 Arsenic Trioxide results in decreased expression of DAB2 mRNA CTD PMID:22521957 dichloroacetic acid decreases expression ISO RGD:30302009 6480464 Dichloroacetic Acid results in decreased expression of DAB2 mRNA CTD PMID:33405312 dichromium trioxide multiple interactions ISO RGD:30302009 6480464 [sodium arsenite co-treated with Cadmium Chloride co-treated with chromic oxide co-treated with chromous chloride co-treated with lead acetate] results in decreased expression of DAB2 mRNA CTD PMID:12634122 diuron decreases expression EXP 6480464 Diuron results in decreased expression of DAB2 mRNA CTD PMID:21551480 dorsomorphin multiple interactions ISO RGD:30302009 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DAB2 mRNA CTD PMID:27188386 doxorubicin decreases expression ISO RGD:30302009 6480464 Doxorubicin results in decreased expression of DAB2 mRNA CTD PMID:29803840 endosulfan decreases expression EXP 6480464 Endosulfan results in decreased expression of DAB2 mRNA CTD PMID:29391264 epoxiconazole increases expression ISO RGD:731452 6480464 epoxiconazole results in increased expression of DAB2 mRNA CTD PMID:35436446 ethanol decreases expression ISO RGD:30302009 6480464 Ethanol results in decreased expression of DAB2 mRNA CTD PMID:23378141 etoposide affects response to substance ISO RGD:30302009 6480464 DAB2 protein affects the susceptibility to Etoposide CTD PMID:16217747 exemestane increases expression ISO RGD:30302009 6480464 exemestane results in increased expression of DAB2 mRNA CTD PMID:17254854 fenamidone increases expression ISO RGD:731452 6480464 fenamidone results in increased expression of DAB2 mRNA CTD PMID:27029645 fipronil increases expression EXP 6480464 fipronil results in increased expression of DAB2 mRNA CTD PMID:23962444 flutamide decreases expression EXP 6480464 Flutamide results in decreased expression of DAB2 mRNA CTD PMID:24793618 fragrance increases expression ISO RGD:30302009 6480464 Perfume results in increased expression of DAB2 mRNA CTD PMID:24768652 fulvestrant multiple interactions ISO RGD:30302009 6480464 [bisphenol A co-treated with Fulvestrant] results in increased methylation of DAB2 gene CTD PMID:31601247 furan increases expression EXP 6480464 furan results in increased expression of DAB2 mRNA CTD PMID:27387713 gold atom increases expression ISO RGD:30302009 6480464 Gold results in increased expression of DAB2 mRNA CTD PMID:29705079 gold(0) increases expression ISO RGD:30302009 6480464 Gold results in increased expression of DAB2 mRNA CTD PMID:29705079 hexadecanoic acid increases phosphorylation ISO RGD:30302009 6480464 Palmitic Acid results in increased phosphorylation of DAB2 protein CTD PMID:28073184 hydrogen peroxide affects expression ISO RGD:30302009 6480464 Hydrogen Peroxide affects the expression of DAB2 mRNA CTD PMID:20044591 hydrogen peroxide multiple interactions ISO RGD:30302009 6480464 [Hydrogen Peroxide co-treated with Theophylline] results in decreased expression of DAB2 protein CTD PMID:18951874 hypochlorous acid decreases expression ISO RGD:731452 6480464 Hypochlorous Acid results in decreased expression of DAB2 mRNA CTD PMID:19376150 ivermectin decreases expression ISO RGD:30302009 6480464 Ivermectin results in decreased expression of DAB2 protein CTD PMID:32959892 juglone affects phosphorylation ISO RGD:30302009 6480464 juglone affects the phosphorylation of DAB2 protein CTD PMID:12881709 L-ascorbic acid decreases expression ISO RGD:731452 6480464 Ascorbic Acid results in decreased expression of DAB2 mRNA CTD PMID:15305145 lead diacetate multiple interactions ISO RGD:30302009 6480464 [sodium arsenite co-treated with Cadmium Chloride co-treated with chromic oxide co-treated with chromous chloride co-treated with lead acetate] results in decreased expression of DAB2 mRNA CTD PMID:12634122 lipopolysaccharide multiple interactions ISO RGD:30302009 6480464 [S-(1, 2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of DAB2 mRNA CTD PMID:35811015 lipopolysaccharide decreases expression ISO RGD:30302009 6480464 Lipopolysaccharides results in decreased expression of DAB2 mRNA CTD PMID:35811015 methotrexate affects expression ISO RGD:731452 6480464 Methotrexate affects the expression of DAB2 mRNA CTD PMID:18502557 methylphenidate increases expression ISO RGD:731452 6480464 Methylphenidate results in increased expression of DAB2 mRNA CTD PMID:22470460 N-methyl-N'-nitro-N-nitrosoguanidine increases expression ISO RGD:30302009 6480464 Methylnitronitrosoguanidine results in increased expression of DAB2 mRNA CTD PMID:12634122 , PMID:12773770 N-nitrosodiethylamine increases expression EXP 6480464 Diethylnitrosamine results in increased expression of DAB2 mRNA CTD PMID:19638242 nickel atom increases expression ISO RGD:30302009 6480464 Nickel results in increased expression of DAB2 mRNA CTD PMID:24768652 , PMID:25583101 nickel dichloride decreases expression ISO RGD:30302009 6480464 nickel chloride results in decreased expression of DAB2 mRNA CTD PMID:17312168 nimesulide decreases expression EXP 6480464 nimesulide results in decreased expression of DAB2 mRNA CTD PMID:24136188 okadaic acid affects phosphorylation ISO RGD:30302009 6480464 Okadaic Acid affects the phosphorylation of DAB2 protein CTD PMID:12881709 oxaliplatin increases expression EXP 6480464 Oxaliplatin results in increased expression of DAB2 mRNA CTD PMID:25729387 oxaliplatin multiple interactions EXP 6480464 [Oxaliplatin co-treated with Topotecan] results in increased expression of DAB2 mRNA CTD PMID:25729387 paracetamol decreases expression EXP 6480464 Acetaminophen results in decreased expression of DAB2 mRNA CTD PMID:33387578 perfluorooctanoic acid multiple interactions ISO RGD:30302009 6480464 [Plasticizers co-treated with Cosmetics co-treated with Flame Retardants co-treated with perfluorooctanoic acid co-treated with Phytoestrogens] results in increased expression of DAB2 mRNA CTD PMID:33325755 phenobarbital affects expression ISO RGD:30302009 6480464 Phenobarbital affects the expression of DAB2 mRNA CTD PMID:19159669 phenylmercury acetate increases expression ISO RGD:30302009 6480464 Phenylmercuric Acetate results in increased expression of DAB2 mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO RGD:30302009 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DAB2 mRNA CTD PMID:27188386 PhIP increases expression EXP 6480464 2-amino-1-methyl-6-phenylimidazo(4, 5-b)pyridine results in increased expression of DAB2 mRNA CTD PMID:15215175 phytoestrogen multiple interactions ISO RGD:30302009 6480464 [Plasticizers co-treated with Cosmetics co-treated with Flame Retardants co-treated with perfluorooctanoic acid co-treated with Phytoestrogens] results in increased expression of DAB2 mRNA CTD PMID:33325755 pirinixic acid multiple interactions ISO RGD:30302009 6480464 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of DAB2 mRNA CTD PMID:19710929 potassium chromate multiple interactions ISO RGD:30302009 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of DAB2 mRNA CTD PMID:22079256 potassium chromate decreases expression ISO RGD:30302009 6480464 potassium chromate(VI) results in decreased expression of DAB2 mRNA CTD PMID:22079256 quercetin decreases expression ISO RGD:30302009 6480464 Quercetin results in decreased expression of DAB2 mRNA CTD PMID:21632981 S-(1,2-dichlorovinyl)-L-cysteine multiple interactions ISO RGD:30302009 6480464 [S-(1, 2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of DAB2 mRNA CTD PMID:35811015 SB 431542 multiple interactions ISO RGD:30302009 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DAB2 mRNA CTD PMID:27188386 silicon dioxide increases expression ISO RGD:30302009 6480464 Silicon Dioxide results in increased expression of DAB2 mRNA CTD PMID:25351596 silicon dioxide increases expression EXP 6480464 Silicon Dioxide results in increased expression of DAB2 mRNA CTD PMID:22431001 silver atom decreases expression ISO RGD:731452 6480464 Silver results in decreased expression of DAB2 mRNA CTD PMID:27131904 silver(0) decreases expression ISO RGD:731452 6480464 Silver results in decreased expression of DAB2 mRNA CTD PMID:27131904 sodium arsenate multiple interactions ISO RGD:30302009 6480464 [sodium arsenate results in increased abundance of Arsenic] which results in increased expression of DAB2 mRNA CTD PMID:32525701 sodium arsenite increases expression ISO RGD:731452 6480464 sodium arsenite results in increased expression of DAB2 protein CTD PMID:29044176 sodium arsenite multiple interactions ISO RGD:30302009 6480464 [sodium arsenite co-treated with Cadmium Chloride co-treated with chromic oxide co-treated with chromous chloride co-treated with lead acetate] results in decreased expression of DAB2 mRNA more ... CTD PMID:12634122 , PMID:29044176 sodium dichromate decreases expression ISO RGD:30302009 6480464 sodium bichromate results in decreased expression of DAB2 mRNA CTD PMID:17685462 succimer multiple interactions ISO RGD:731452 6480464 [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of DAB2 mRNA CTD PMID:21641980 sulforaphane decreases expression ISO RGD:30302009 6480464 sulforaphane results in decreased expression of DAB2 mRNA CTD PMID:31838189 sunitinib decreases expression ISO RGD:30302009 6480464 Sunitinib results in decreased expression of DAB2 mRNA CTD PMID:31533062 testosterone enanthate affects expression ISO RGD:30302009 6480464 testosterone enanthate affects the expression of DAB2 mRNA CTD PMID:17440010 tetrachloromethane increases expression ISO RGD:731452 6480464 Carbon Tetrachloride results in increased expression of DAB2 mRNA, Carbon Tetrachloride results in increased expression of DAB2 protein CTD PMID:29044176 , PMID:31919559 tetradecane decreases expression EXP 6480464 n-tetradecane results in decreased expression of DAB2 protein CTD PMID:17337753 theophylline multiple interactions ISO RGD:30302009 6480464 [Hydrogen Peroxide co-treated with Theophylline] results in decreased expression of DAB2 protein CTD PMID:18951874 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of DAB2 mRNA CTD PMID:34492290 titanium dioxide increases expression ISO RGD:731452 6480464 titanium dioxide results in increased expression of DAB2 mRNA CTD PMID:23557971 titanium dioxide decreases expression ISO RGD:731452 6480464 titanium dioxide results in decreased expression of DAB2 mRNA CTD PMID:29264374 topotecan multiple interactions EXP 6480464 [Oxaliplatin co-treated with Topotecan] results in increased expression of DAB2 mRNA CTD PMID:25729387 topotecan increases expression EXP 6480464 Topotecan results in increased expression of DAB2 mRNA CTD PMID:25729387 trichloroethene decreases expression EXP 6480464 Trichloroethylene results in decreased expression of DAB2 mRNA CTD PMID:33387578 trichostatin A increases expression ISO RGD:30302009 6480464 trichostatin A results in increased expression of DAB2 mRNA CTD PMID:24935251 triclosan increases expression ISO RGD:30302009 6480464 Triclosan results in increased expression of DAB2 mRNA CTD PMID:30510588 trimellitic anhydride decreases expression ISO RGD:731452 6480464 trimellitic anhydride results in decreased expression of DAB2 mRNA CTD PMID:19042947 triptonide affects expression ISO RGD:731452 6480464 triptonide affects the expression of DAB2 mRNA CTD PMID:33045310 tris(2-butoxyethyl) phosphate affects expression ISO RGD:30302009 6480464 tris(2-butoxyethyl) phosphate affects the expression of DAB2 mRNA CTD PMID:29024780 undecane increases expression EXP 6480464 undecane results in increased expression of DAB2 protein CTD PMID:17337753 urethane decreases expression ISO RGD:30302009 6480464 Urethane results in decreased expression of DAB2 mRNA CTD PMID:28818685 valproic acid increases expression ISO RGD:731452 6480464 Valproic Acid results in increased expression of DAB2 mRNA CTD PMID:24896083 valproic acid decreases expression ISO RGD:30302009 6480464 Valproic Acid results in decreased expression of DAB2 mRNA CTD PMID:29154799 valproic acid affects expression ISO RGD:30302009 6480464 Valproic Acid affects the expression of DAB2 mRNA CTD PMID:25979313 venlafaxine hydrochloride increases expression EXP 6480464 Venlafaxine Hydrochloride results in increased expression of DAB2 mRNA CTD PMID:25423262 vinclozolin affects expression EXP 6480464 vinclozolin affects the expression of DAB2 mRNA CTD PMID:19015723